Cargando…

Hybrid cardiac telerehabilitation for coronary artery disease in Australia: a cost-effectiveness analysis

BACKGROUND: Traditional cardiac rehabilitation programs are centre-based and clinically supervised, with their safety and effectiveness well established. Notwithstanding the established benefits, cardiac rehabilitation remains underutilised. A possible alternative would be a hybrid approach where bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Senanayake, Sameera, Halahakone, Ureni, Abell, Bridget, Kularatna, Sanjeewa, McCreanor, Victoria, McPhail, Steven M., Redfern, Julie, Tom Briffa, Parsonage, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198753/
https://www.ncbi.nlm.nih.gov/pubmed/37208666
http://dx.doi.org/10.1186/s12913-023-09546-w
_version_ 1785044802183626752
author Senanayake, Sameera
Halahakone, Ureni
Abell, Bridget
Kularatna, Sanjeewa
McCreanor, Victoria
McPhail, Steven M.
Redfern, Julie
Tom Briffa
Parsonage, William
author_facet Senanayake, Sameera
Halahakone, Ureni
Abell, Bridget
Kularatna, Sanjeewa
McCreanor, Victoria
McPhail, Steven M.
Redfern, Julie
Tom Briffa
Parsonage, William
author_sort Senanayake, Sameera
collection PubMed
description BACKGROUND: Traditional cardiac rehabilitation programs are centre-based and clinically supervised, with their safety and effectiveness well established. Notwithstanding the established benefits, cardiac rehabilitation remains underutilised. A possible alternative would be a hybrid approach where both centre-based and tele-based methods are combined to deliver cardiac rehabilitation to eligible patients. The objective of this study was to determine the long-term cost-effectiveness of a hybrid cardiac telerehabilitation and if it should be recommended to be implemented in the Australian context. METHODS: Following a comprehensive literature search, we chose the Telerehab III trial intervention that investigated the effectiveness of a long-term hybrid cardiac telerehabilitation program. We developed a decision analytic model to estimate the cost-effectiveness of the Telerehab III trial using a Markov process. The model included stable cardiac disease and hospitalisation health states and simulations were run using one-month cycles over a five-year time horizon. The threshold for cost-effectiveness was set at $AU 28,000 per quality-adjusted life-year (QALY). For the base analysis, we assumed that 80% completed the programme. We tested the robustness of the results using probabilistic sensitivity and scenario analyses. RESULTS: Telerehab III intervention was more effective but more costly and was not cost-effective, at a threshold of $28,000 per QALY. For every 1,000 patients who undergo cardiac rehabilitation, employing the telerehabilitation intervention would cost $650,000 more, and 5.7 QALYs would be gained, over five years, compared to current practice. Under probabilistic sensitivity analysis, the intervention was cost-effective in only 18% of simulations. Similarly, if the intervention compliance was increased to 90%, it was still unlikely to be cost-effective. CONCLUSION: Hybrid cardiac telerehabilitation is highly unlikely to be cost-effective compared to the current practice in Australia. Exploration of alternative models of delivering cardiac telerehabilitation is still required. The results presented in this study are useful for policymakers wanting to make informed decisions about investment in hybrid cardiac telerehabilitation programs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-023-09546-w.
format Online
Article
Text
id pubmed-10198753
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101987532023-05-21 Hybrid cardiac telerehabilitation for coronary artery disease in Australia: a cost-effectiveness analysis Senanayake, Sameera Halahakone, Ureni Abell, Bridget Kularatna, Sanjeewa McCreanor, Victoria McPhail, Steven M. Redfern, Julie Tom Briffa Parsonage, William BMC Health Serv Res Research BACKGROUND: Traditional cardiac rehabilitation programs are centre-based and clinically supervised, with their safety and effectiveness well established. Notwithstanding the established benefits, cardiac rehabilitation remains underutilised. A possible alternative would be a hybrid approach where both centre-based and tele-based methods are combined to deliver cardiac rehabilitation to eligible patients. The objective of this study was to determine the long-term cost-effectiveness of a hybrid cardiac telerehabilitation and if it should be recommended to be implemented in the Australian context. METHODS: Following a comprehensive literature search, we chose the Telerehab III trial intervention that investigated the effectiveness of a long-term hybrid cardiac telerehabilitation program. We developed a decision analytic model to estimate the cost-effectiveness of the Telerehab III trial using a Markov process. The model included stable cardiac disease and hospitalisation health states and simulations were run using one-month cycles over a five-year time horizon. The threshold for cost-effectiveness was set at $AU 28,000 per quality-adjusted life-year (QALY). For the base analysis, we assumed that 80% completed the programme. We tested the robustness of the results using probabilistic sensitivity and scenario analyses. RESULTS: Telerehab III intervention was more effective but more costly and was not cost-effective, at a threshold of $28,000 per QALY. For every 1,000 patients who undergo cardiac rehabilitation, employing the telerehabilitation intervention would cost $650,000 more, and 5.7 QALYs would be gained, over five years, compared to current practice. Under probabilistic sensitivity analysis, the intervention was cost-effective in only 18% of simulations. Similarly, if the intervention compliance was increased to 90%, it was still unlikely to be cost-effective. CONCLUSION: Hybrid cardiac telerehabilitation is highly unlikely to be cost-effective compared to the current practice in Australia. Exploration of alternative models of delivering cardiac telerehabilitation is still required. The results presented in this study are useful for policymakers wanting to make informed decisions about investment in hybrid cardiac telerehabilitation programs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-023-09546-w. BioMed Central 2023-05-20 /pmc/articles/PMC10198753/ /pubmed/37208666 http://dx.doi.org/10.1186/s12913-023-09546-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Senanayake, Sameera
Halahakone, Ureni
Abell, Bridget
Kularatna, Sanjeewa
McCreanor, Victoria
McPhail, Steven M.
Redfern, Julie
Tom Briffa
Parsonage, William
Hybrid cardiac telerehabilitation for coronary artery disease in Australia: a cost-effectiveness analysis
title Hybrid cardiac telerehabilitation for coronary artery disease in Australia: a cost-effectiveness analysis
title_full Hybrid cardiac telerehabilitation for coronary artery disease in Australia: a cost-effectiveness analysis
title_fullStr Hybrid cardiac telerehabilitation for coronary artery disease in Australia: a cost-effectiveness analysis
title_full_unstemmed Hybrid cardiac telerehabilitation for coronary artery disease in Australia: a cost-effectiveness analysis
title_short Hybrid cardiac telerehabilitation for coronary artery disease in Australia: a cost-effectiveness analysis
title_sort hybrid cardiac telerehabilitation for coronary artery disease in australia: a cost-effectiveness analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198753/
https://www.ncbi.nlm.nih.gov/pubmed/37208666
http://dx.doi.org/10.1186/s12913-023-09546-w
work_keys_str_mv AT senanayakesameera hybridcardiactelerehabilitationforcoronaryarterydiseaseinaustraliaacosteffectivenessanalysis
AT halahakoneureni hybridcardiactelerehabilitationforcoronaryarterydiseaseinaustraliaacosteffectivenessanalysis
AT abellbridget hybridcardiactelerehabilitationforcoronaryarterydiseaseinaustraliaacosteffectivenessanalysis
AT kularatnasanjeewa hybridcardiactelerehabilitationforcoronaryarterydiseaseinaustraliaacosteffectivenessanalysis
AT mccreanorvictoria hybridcardiactelerehabilitationforcoronaryarterydiseaseinaustraliaacosteffectivenessanalysis
AT mcphailstevenm hybridcardiactelerehabilitationforcoronaryarterydiseaseinaustraliaacosteffectivenessanalysis
AT redfernjulie hybridcardiactelerehabilitationforcoronaryarterydiseaseinaustraliaacosteffectivenessanalysis
AT tombriffa hybridcardiactelerehabilitationforcoronaryarterydiseaseinaustraliaacosteffectivenessanalysis
AT parsonagewilliam hybridcardiactelerehabilitationforcoronaryarterydiseaseinaustraliaacosteffectivenessanalysis